Virus References

Mind-Body Effects, Nutrition, AIDS 

Mind-Body Effects

  1. Ewin DM. Hypnotherapy for warts (verruca vulgaris): 41 consecutive cases with 33 cures.  Am J Clin Hypn. 1992 Jul; 35(1): 1-10. Abstract 
  2. Fox PA, Henderson DC, Barton SE, et al. Immunological markers of frequently recurrent genital herpes simplex virus and their response to hypnotherapy: a pilot study.  Int J STD AIDS. 1999 Nov; 10(11): 730-4. Abstract 
  3. Gould SS, Tissler DM. The use of hypnosis in the treatment of herpes simplex II.   Am J Clin Hypn. 1984 Jan; 26(3): 171-4. Abstract 
  4. Gruzelier JH.  A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress. 2002 Jun; 5(2): 147-63.   Abstract 
  5. Gruzelier JH, Champion A, Fox P, et al.  Individual differences in personality, immunology and mood in patients undergoing self-hypnosis training for the successful treatment of a chronic viral illness, HSV-2. Contem Hypn 2002; vol 4 (19)  pp. 149-166  Abstract 
  6. Langenfeld MC, Cipani E, Borckardt JJ.  Hypnosis for the control of HIV/AIDS-related pain.   Int J Clin Exp Hypn. 2002 Apr; 50(2): 170-88.  Abstract 
  7. Rucklidge JJ, Saunders D.  The efficacy of hypnosis in the treatment of pruritus in people with HIV/AIDS: a time-series analysis. Int J Clin Exp Hypn. 2002 Apr; 50(2): 149-69.  Abstract 
  8. Spanos NP, Williams V, Gwynn MI.  Effects of hypnotic, placebo, and salicylic acid treatments on wart regression.  Psychosom Med. 1990 Jan-Feb; 52(1): 109-14.    Abstract 
  9. Taylor DN.  Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV positive men. Psychol Rep. 1995 Apr; 76(2): 451-7.   Abstract 
  • Nutrition
    1. Bobat R, Coovadia H, Stephen C, et al.  Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial.   Lancet. 2005 Nov 26; 366(9500): 1862-7.   Abstract 
    2. Broome CS, McArdle F, Kyle JA, et al.  An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status.   Am J Clin Nutr. 2004 Jul; 80(1): 154-62.  Abstract 
    3. Coodley G.  Update on vitamins, minerals, and the carotenoids. J Physicians Assoc AIDS Care. 1995 Jan; 2(1): 24-9  Abstract 
    4. Czuczejko J, Zachara BA, Staubach-Topczewska E, et al.  Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases.   Acta Biochim Pol. 2003; 50(4): 1147-54. Abstract    | Full text 
    5. Diamond AM, Hu YJ, Mansur DB.   Glutathione peroxidase and viral replication: implications for viral evolution and chemoprevention. Biofactors. 2001; 14(1-4): 205-10  Abstract 
    6. Ferencik M, Ebringer L.  Modulatory effects of selenium and zinc on the immune system.   Folia Microbiol (Praha). 2003; 48(3): 417-26. Abstract 
    7. Hara M, Tanaka K, Hirota Y.  Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status.Vaccine. 2005 Feb 10; 23(12): 1457-63. Abstract 
    8. Hovi T, Hirvimies A, Stenvik M, et al. Topical treatment of recurrent mucocutaneous herpes with ascorbic acid-containing solution. Antiviral Res. 1995 Jun; 27(3): 263-70.   Abstract 
    9. Ko WS, Guo CH, Yeh MS, et al.   Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol. 2005 Aug 14; 11(30): 4697-702.  Abstract | Full text 
    10. Kupka R, Garland M, Msamanga G, et al.  Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1.   J Acquir Immune Defic Syndr. 2005 Jun 1; 39(2): 203-10.   Abstract 
    11. Landwehr, R  The Origin of the 42-Year Stonewall of Vitamin C   From Journal of Orthomolecular Medicine, Vol 6(2) 1991, pp. 99-103 Full text 
    12. Rayman MP.  The use of high-selenium yeast to raise selenium status: how does it measure up?   Br J Nutr. 2004 Oct; 92(4): 557-73. Abstract 
    13. Rayman MP.  The importance of selenium to human health. The Lancet.  July 15, 2000 v356 i9225 pp233-41  Abstract 
    14. Rayman MP. Dietary selenium: time to act.   BMJ. 1997 Feb 8; 314(7078): 387-8  Full text 
    15. Ryan-Harshman M, Aldoori W.   The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases.  Can J Diet Pract Res. 2005 Summer; 66(2): 98-102.  Abstract 
    16. Srinivasan V, Maestroni G, Cardinali D, et al.  Melatonin, immune function and aging.

      17. Immun Ageing. 2005 Nov 29; 2: 17.   Abstract  |  Full text
    17. Taylor, E.W. (1997). Selenium and viral diseases: Facts and hypotheses. Journal of Orthomolecular Medicine, 12(4), 227-239.  Ref  [No abstract available]
    18. van Lettow M, Harries AD, Kumwenda JJ, et al.  Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi.   BMC Infect Dis. 2004 Dec 21; 4(1): 61.  Abstract  |  Full text 
    19. van Lettow M, West CE, van der Meer JW, et al.   Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi.   Eur J Clin Nutr. 2005 Apr; 59(4): 526-32. Abstract 
    20. Zhang W, Ramanathan CS, Nadimpalli RG, et al.  Selenium-dependent glutathione peroxidase modules encoded by RNA viruses.  Biol Trace Elem Res. 1999 Nov; 70(2): 97-116.   Abstract 

    AIDS

    1. Allard JP, Aghdassi E, Chau J, et al.  Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection.  Am J Clin Nutr. 1998 Jan; 67(1): 143-7.  Abstract |  Full text 
    2. Allavena C, Dousset B, May T, et al.   Relationship of trace element, immunological markers, and HIV1 infection progression. Biol Trace Elem Res. 1995 Jan-Mar; 47(1-3): 133-8.  Abstract 
    3. Baeten JM, Mostad SB, Hughes MP, et al.   Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.    J Acquir Immune Defic Syndr. 2001 Apr 1; 26(4): 360-4.   Abstract 
    4. Baum MK.  Role of micronutrients in HIV-infected intravenous drug users.  J Acquir Immune Defic Syndr. 2000 Oct 1; 25 Suppl 1: S49-52.   Abstract 
    5. Baum MK, Miguez-Burbano MJ, Campa A, Shor-Posner G.  Selenium and interleukins in persons infected with human immunodeficiency virus type 1.   J Infect Dis. 2000 Sep; 182 Suppl 1: S69-73. Abstract 
    6. Baum MK, Shor-Posner G, Lai S, et al.  High risk of HIV-related mortality is associated with selenium deficiency.   J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;  15(5):  370-4.  Abstract 
    7. Baum MK, Shor-Posner G, Zhang G, et al.  HIV-1 infection in women is associated with severe nutritional deficiencies.  J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1; 16(4): 272-8. Abstract 
    8. Burbano X, Miguez-Burbano MJ, McCollister K, et al.  Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants.    HIV Clin Trials. 2002 Nov-Dec; 3(6): 483-91. Abstract 
    9. Busch MP, Henrard DR, Hewlett IK, et al.  Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction.   J Acquir Immune Defic Syndr. 1992; 5(9): 872-7.  Abstract 
    10. Campa A, Shor-Posner G, Indacochea F, et al.  Mortality risk in selenium-deficient HIV-positive children.   J. Acquir. Immune Defic. Syndrome Hum. Retrovirol.1999 Apr 15; 20(5): 508-513. Abstract
    11. Cathcart RF 3rd  Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS).  Med Hypotheses. 1984 Aug; 14(4): 423-33  Abstract 
    12. Cowgill UM.  The distribution of selenium and mortality owing to acquired immune deficiency syndrome in the continental United States.Biol Trace Elem Res. 1997 Jan; 56(1): 43-61.   Abstract 
    13. Das UN.   Essential fatty acids and acquired immunodeficiency syndrome.   Med Sci Monit. 2005 Jun; 11(6): RA206-211. Abstract  |  Full text
    14. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al.   The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene.   Am J Clin Nutr. 1996 Jul; 64(1): 101-7.   Abstract 
    15. Diamond AM, Hu YJ, Mansur DB.  Glutathione peroxidase and viral replication: implications for viral evolution and chemoprevention.Biofactors. 2001; 14(1-4): 205-10.   Abstract 
    16. Dodig S, Cepelak I.  The facts and controversies about selenium.Acta Pharm. 2004 Dec; 54(4): 261-76.  Abstract 
    17. Drain PK, Baeten JM, Overbaugh J, et al.   Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women.    BMC Infect Dis. 2006 May 19; 6(1): 85   Abstract |  Full text 
    18. Dworkin BM.  Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS).   Chem Biol Interact. 1994 Jun; 91(2-3): 181-6.  Abstract 
    19. Dworkin BM, Rosenthal WS, Wormser GP, et al.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex.   Biol Trace Elem Res. 1988 Jan-Apr; 15: 167-77.   Abstract 
    20. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L.   Selenium deficiency in the acquired immunodeficiency syndrome.   JPEN J Parenter Enteral Nutr. 1986 Jul-Aug; 10(4): 405-7.   Abstract 
    21. Elechiguerra JL, Burt JL, Morones JR, et al.    Interaction of silver nanoparticles with HIV-1.    J Nanobiotechnology. 2005 Jun 29; 3: 6.  Abstract |  Full text 
    22. Fawzi W, Msamanga G, Spiegelman D, Hunter DJ.  Studies of Vitamins and Minerals and HIV Transmission and Disease Progression.  J Nutr. 2005 Apr; 135(4): 938-44.  Abstract 
    23. Ferencik M, Ebringer L.  Modulatory effects of selenium and zinc on the immune system.   Folia Microbiol (Praha). 2003; 48(3): 417-26.   Abstract 
    24. Foster HD.  What Really Causes AIDS   Trafford Publishing. 2002
    25. Foster HD.   AIDS: THE SELENO-ENZYME SOLUTION  Nexus Magazine, Vol 11 (1); (December-January 2004)  Full text 
    26. Foster HD.  How HIV-1 causes AIDS: implications for prevention and treatment.   Med Hypotheses. 2004; 62(4): 549-53 Abstract 
    27. Gladyshev VN, Stadtman TC, Hatfield DL, Jeang KT.  Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase.    Proc Natl Acad Sci U S A. 1999 Feb 2; 96(3): 835-9.     Abstract |  Full text 
    28. Hurwitz BE, Klaus JR, Llabre MM, et al.  Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.   Arch Intern Med. 2007 Jan 22; 167(2): 148-54.   Abstract 
    29. Johnson, Christine. HIV and False Positive testing:  Full text 
    30. Kupka R, Msamanga GI, Spiegelman D, et al.  Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers.    Eur J Clin Nutr. 2005 Nov; 59(11): 1250-8.   Abstract 
    31. Kupka R, Msamanga GI, Spiegelman D, et al.  Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania.  J Nutr. 2004 Oct; 134(10): 2556-60.   Abstract 
    32. Lissoni P, Vigore L, Rescaldani R, et al.  Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study.  J Biol Regul Homeost Agents. 1995 Oct-Dec; 9(4): 155-8.  Abstract 
    33. Look MP, Rockstroh JK, Rao GS, et al.  Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection.Eur J Clin Nutr. 1997 Apr; 51(4): 266-72.  Abstract 
    34. Luty-Frackiewicz A.   The role of selenium in cancer and viral infection prevention.   Int J Occup Med Environ Health. 2005; 18(4): 305-11.   Abstract 
    35. Makropoulos V, Bruning T, Schulze-Osthoff K.   Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity.Arch Toxicol. 1996; 70(5): 277-83.   Abstract 
    36. McCarty MF.  A general strategy for the use of allogeneic lymphocyte infusions in the treatment of disorders characterized by impaired helper or suppressor T cell function: autoimmune diseases and the acquired immunodeficiency syndrome (AIDS).  Med Hypotheses. 1985 Mar; 16(3): 189-20 Abstract 
    37. McDermid JM, Lalonde RG, Gray-Donald K, et al.   Associations between dietary antioxidant intake and oxidative stress in HIV-seropositive and HIV-seronegative men and women.   J Acquir Immune Defic Syndr. 2002 Feb 1; 29(2): 158-64.   Abstract 
    38. [No authors listed]   Selenium   Altern Med Rev. 2003 Feb; 8(1): 63-71.  Full text 
    39. Ogunro PS, Ogungbamigbe TO, Elemie PO, et al.  Plasma Selenium Concentration and Glutathione Peroxidase Activity in HIV-1/AIDS Infected Patients: A Correlation with the Disease Progression.   Niger Postgrad Med J. 2006 Mar; 13(1): 1-5.  Abstract 
    40. Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J.  Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res. 1989 Apr-May; 20(1-2): 59-65.  Abstract 
    41. Patrick L.  Nutrients and HIV: part one -- beta carotene and selenium. Altern Med Rev. 1999 Dec; 4(6): 403-13   Abstract | Full text 
    42. Patrick L.  Nutrients and HIV: part two--vitamins A and E, zinc, B-vitamins, and magnesium.    Altern Med Rev. 2000 Feb; 5(1): 39-51    Abstract  |  Full text 
    43. Range N, Changalucha J, Krarup H, et al.   The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr. 2006 Apr; 95(4): 762-70.   Abstract 
    44. Rayman MP, Rayman MP.  The argument for increasing selenium intake.Proc Nutr Soc. 2002 May; 61(2): 203-15  Abstract 
    45. Romero-Alvira D, Roche E.   The keys of oxidative stress in acquired immune deficiency syndrome apoptosis.   Med Hypotheses. 1998 Aug; 51(2): 169-73.  Abstract 
    46. Schrauzer GN, Sacher J.  Selenium in the maintenance and therapy of HIV-infected patients.   Chem Biol Interact. 1994 Jun; 91(2-3): 199-205.   Abstract 
    47. Shor-Posner G, Lecusay R, Miguez MJ, et al.   Psychological burden in the era of HAART: impact of selenium therapy.  Int J Psychiatry Med. 2003; 33(1): 55-69.  Abstract 
    48. Shor-Posner G, Miguez MJ, Pineda LM, et al.  Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Feb 1; 29(2): 169-73.  Abstract 
    49. Singhal N, Austin J.  A clinical review of micronutrients in HIV infection.  J Int Assoc Physicians AIDS Care (Chic Ill). 2002 Spring; 1(2): 63-75  Abstract  |  Full text 
    50. Sprietsma JE.   Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer.   Med Hypotheses. 1999 Jul; 53(1): 6-16. Abstract 
    51. Stehbens WE.  Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol. 2004 Oct; 77(2): 121-32.  Abstract 
    52. Taylor EW, Cox AG, Zhao L, et al.   Nutrition, HIV, and drug abuse: the molecular basis of a unique role for selenium.   J Acquir Immune Defic Syndr. 2000 Oct 1; 25 Suppl 1: S53-61  Abstract 
    53. van Lettow M, Harries AD, Kumwenda JJ, et al.  Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi.    BMC Infect Dis. 2004 Dec 21; 4(1): 61.    Abstract  |  Full text 

    Home

    Print this page